Stay updated with breaking news from Sari Rosenberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New data from the completed dose escalation part and ongoing expansion part of Study 1100, an ongoing US Phase 1 study evaluating NBTXR3 followed by anti-PD-1 in patients with recurrent
First-in-human data for potential first-in-class anti-CEACAM5 ADC with topoisomerase 1 inhibitor payload, M9140, in treatment of metastatic colorectal cancer to be featured in oral presentation
HOOKIPA to present an oral abstract at the American Society for Clinical Oncology 2024 Annual Meeting on June 4Updated data of HB-200 plus pembrolizumab demonstrate a favorable safety profile and...
Phase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or...
Campus community discusses 2 resolution petitions about Israel-Hamas war on the ballot in ongoing CSG fall election